[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100353799":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":39,"responsibleParty":59,"collaborators":24,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":24,"eligibilityCriteria":66,"healthyVolunteers":67,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":24,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":42,"whyStopped":24,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Hôpital le Vinatier","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with with neuropsychiatric conditions","EXPERIMENTAL","In this arm, five groups :\n\n* Patients with DFT, diagnosed according Racovsky criteria\n* Patients with Lewi Body dementia, diagnosed according McKeith criteria\n* Patients with pre-demential Alzheimer, diagnosed according Dubois criteria\n* Patients with Alzheimer, diagnosed according MMSE\n* Patients with bipolar disorder, diagnosed according DSM 5",[13],"Other: Monitoring source test",{"label":15,"type":16,"description":17,"interventionNames":18},"Healthy subjects","ACTIVE_COMPARATOR","Healthy controls appaired in age, sex and educational level",[13],[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Monitoring source test","Internal- and external-monitoring correct responses and inversions",[15,9],null,[26],{"name":27,"affiliation":28,"role":29},"JEROME BRUNELIN, PHD","Centre Hospitalier Le Vinatier - CRNL - INSERM","PRINCIPAL_INVESTIGATOR",[31,35],{"name":27,"role":32,"phone":33,"phoneExt":24,"email":34},"CONTACT","00334 37 91 55 65","jerome.brunelin@ch-le-vinatier.fr",{"name":36,"role":32,"phone":37,"phoneExt":24,"email":38},"Jean-Michel DOREY, PHD","00334 37 91 52 49","jean-michel.dorey@ch-le-vinatier.fr",[40],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Centre Hospitalier Le Vinatier","RECRUITING","Bron","Auvergne-Rhône-Alpes","69678","France","FR",{"type":49,"coordinates":50},"Point",[51,52],4.91303,45.73865,{"lat":52,"lon":51},[55],{"name":56,"role":32,"phone":57,"phoneExt":24,"email":58},"VIAL VERONIQUE","0033437915531","veronique.vial@ch-le-vinatier.fr",{"type":60,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100353799","source-monitoring-dficit-in-neuropsychiatric-population-100353799",false,"NCT03886584","Source Monitoring Déficit in Neuropsychiatric Population","Inclusion Criteria:\n\n* Subjects who gave their free and informed consent;\n* Men and women;\n* Aged 18 to 80;\n* Having normal or corrected vision;\n* Mastering the French language (read and spoken);\n* All subjects will not have a working memory deficit preventing the test from being passed (MMSE short version):AM patients should have a score of \\\u003CMMSE \\\u003C26; Patients with pre-dementia AD will be diagnosed according to Dubois criteria (Dubois et al., 2016); patients with early FTD will be diagnosed according to Rascovsky's criteria (Rascovsky et al., 2011); Patients with DCL will be diagnosed according to McKeith's criteria (McKeith et al., 2005), TBP patients will be diagnosed using DSM 5 criteria (Arlington VA, 2013).\n\nExclusion Criteria:\n\n* Inadmissibility of the consent or refusal of the subject.\n* Patients under guardianship",true,"ALL","18 Years","80 Years",{"count":72,"type":73},300,"ESTIMATED","INTERVENTIONAL",[76],"NA","the investigators will measure source-monitoring ability in patients with several neuropsychiatric condition and in healthy controls appaired in age, sex and educational level. Source-monitoring will be measured thanks to internal- and reality-monitoring informatic tasks.The investigators hypothesized patients with fronto-temporal abnormalities would show more marked deficits than patients with only frontal abnormalities.",[79],"Psychiatric Disorder",[81,82],"Bipolar Disorder","Source-monitoring","2025-07-30",{"date":85,"type":86},"2025-07-31","ACTUAL",{"date":88,"type":86},"2019-03-08",{"date":90,"type":73},"2026-07-31",{"name":5,"class":6},1]